Palliative care for people severely affected by multiple sclerosis: evaluation of a novel palliative care service

Abstract

Multiple sclerosis results in both physical and psychological disability but some patients have needs that are not adequately met by existing services. Our objective was to explore whether a new palliative care service improved outcomes for people severely affected by multiple sclerosis. A delayed intervention randomized controlled trial was undertaken with multiple sclerosis patients deemed by staff to have palliative care needs. The intervention was a multiprofessional palliative care team assessment and follow-up. The intervention group was offered the team immediately (fast track, FI); the control group continued best standard care and then offered the team after 3 months (standard intervention, SI). The main outcome measures were: patient reported issues using the Palliative Care Outcome Scale and Multiple Sclerosis Impact Scale at 12 weeks and caregiver burden using the Zarit Burden Inventory. Sixty-nine people were referred to the service; 52 consented or were eligible to be randomized (26 to the FI and 26 to the SI groups). At 12 weeks people in the FI group had an improvement (mean change —1.0) in the total score of 5 key symptoms whereas there was deterioration in the SI group (mean change 1.1, F = 4.75, p = 0.035). There was no difference in the change in general Palliative Care Outcome Scale or Multiple Sclerosis Impact Scale scores. There was an improvement in caregiver burden in the FI group and a deterioration in the SI group (F = 7.60, p = 0.013). Involvement with the palliative care service appeared to positively affect some key symptoms and reduced informal caregiver burden.

Keywords

multiple sclerosis palliative care randomized controlled trial

Get full access to this article

View all access options for this article.

References

Compson A. Demyelinating disorders of the central nervous system. In: Warrell DA , Cox TM , Firth JD , Benz Jr EJ (eds) Oxford textbook of medicine. Oxford: Oxford University Press, 2003.

Degenhardt A. , Ramagopalan SV , Scalfari A. , Ebers GC Clinical prognostic factors in multiple sclerosis: a natural history. Nat Rev Neurol 2009; 5: 672-682.

Sadnovnick AD , Ebers GC , Wilson RW , Paty DW Life expectancy in patients attending multiple sclerosis clinics. Neurology 1992; 42: 991-994.

Edmonds P. , Vivat B. , Silber E. , Burman R. , Higginson IJ ‘‘Fighting for everything’’: experiences of people severely affected by multiple sclerosis. Mult Scler 2006; 12: 1-8.

Buchanan R. , Radin D. , Chakravorty BJ , Tyry T. Perceptions of informal care givers: health and support services provided to people with multiple sclerosis. Disabil Rehabil 2010; 32(6): 500-510.

Addington-Hall JM 1998. Reaching out: specialist palliative care for adults with non-malignant disease. Report. London: National Council for Hospice and Specialist Palliative Care Services.

Higginson IJ , Hart S. , Silber E. , Burman R. , Edmonds P. Symptom prevalence and severity amongst people severely affected by multiple sclerosis (MS). J Palliat Care 2006; 22: 158-165.

O’Brien T. Neurodegenerative disease. In: Addington-Hall JM , Higginson IJ (eds) Palliative care for non-cancer patients. Oxford: Oxford University Press, 2001, p.44-55.

Kümpfel T. , Hoffmann LA , Pölmann W. , et al. Palliative care in patients with severe multiple sclerosis: two case reports and a survey among German MS neurologists . Palliat Med 2007; 21: 109-114.

10.

Higginson IJ , Finlay IG , Goodwin DM , et al. The role of palliative care teams: systematic review of their effectiveness and cost-effectiveness. Report to Wales Office of Research and Development of the National Assembly of Wales. London: Department of Palliative Care and Policy, Velindre NHS Trust and Department of General Practice, UWCM, 2000 .

11.

Edmonds P. , Vivat B. , Silber E. , Burman R. , Higginson IJ Loss and change: experiences of people severely affected by multiple sclerosis . Palliat Med 2007; 21: 101-107.

12.

Higginson IJ , Vivat B. , Silber E. , et al. Study protocol: delayed intervention randomised controlled trial within Medical Research Council (MRC) Framework to assess the effectiveness of a new palliative care service. BMC Palliat Care 2006; 5: 7 http://www.biomedcentral.com/1472-684X/5/7

13.

Higginson IJ , Hart S. , Burman R. , et al. Randomised controlled trial of a new palliative care service: Compliance, recruitment and completeness of follow-up. BMC Palliat Care 2008; 7: 7 http://www.biomedcentral.com/1472-684X/7/7 (Accessed 14/11/2009).

14.

Weinschenker BG , Rice GP , Noseworthy JH , Carriere W. , Baskerville J. , Ebers GC The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcome. Brain 1991; 114: 1045-1056.

15.

World Health Organization. WHO Definition of Palliative Care. http://www.who.int/cancer/palliative/definition/en/ (Accessed 14/11/2009).

16.

Rossier P. , Wade DT The Guy’s Neurological Disability Scale in patients with multiple sclerosis: a clinical evaluation of its reliability and validity. Clin Rehabil 2002; 16: 75-95.

17.

Kurtzke JF Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-1452.

18.

Hodkinson HM Evaluation of a mental test score for assessment of mental impairment in the elderly. Age Ageing 1972; 1: 233-238.

19.

Hobart J. , Lamping D. , Fitzpatrick R. , Riazi A. , Thompson A. The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure. Brain 2001; 124: 962-973.

20.

Hearn J. , Higginson IJ Development and validation of a core outcome measure for palliative care: the palliative care outcome scale. Qual Health Care 1999; 8: 219-227.

21.

Higginson IJ , Donaldson N. Relationship between three palliative care outcome scales. Health Qual Life Outcomes 2004; 2: 68-75.

22.

Bedard M. , Molloy DW , Squire L. , Dubois S. , Lever JA , O’Donnell M. The Zarit Burden Interview: a new short version and screening version. Gerontologist 2001; 41: 652-657.

23.

Lawton MP , Moss M. , Kleban MH , Glicksman A. , Rovine M. A two-factor model of caregiving appraisal and psychological well-being. J Gerontol: Psychol Sci 1991; 46: P181-P189.

24.

Gruenewald DA , Higginson IJ , Vivat B. , Edmonds P. , Burman RE Quality of life measures for the palliative care of people severely affected by multiple sclerosis: a systematic review . Mult Scler 2004; 10: 690-725.

25.

Engles JM , Diehr P. Imputation of missing longitudinal data: a comparison of methods. J Clin Epidemiol 2003; 56: 968-976.

26.

Cohen J. Statistical power analysis for the behavioural sciences, 2nd edn. Hillsdale, NJ: Lawrence Earlbaum Associates, 1988.

27.

Jack B. , Hillier V. , Williams A. , Oldham J. Hospital based palliative care teams improve the symptoms of cancer patients . Palliat Med 2003; 17: 498-502.

28.

Chia EM , Chia EM , Rochtchina E. , Wang JJ , Mitchell P. Utility and validity of the self-administered SF-36: findings from an older population. Ann Acad Med Singapore 2006; 35: 461-467.

29.

Turner-Stokes L. , Sykes N. , Silber E. Long term neurological conditions: management at the interface between neurology, rehabilitation and palliative care. Clin Med 2008; 8: 186-191.

30.

O’Leary N. , Tiernan E. Survey of specialist palliative care services for noncancer patients in Ireland and perceived barriers. Palliat Med 2008; 22: 77-83.

31.

Dharmasena HP , Forbes K.

Palliative care for patients with non-malignant disease: will hospital physicians refer?

Palliat Med 2001; 15: 413-418.